Also published as Diego Pinzon Rubiano
Somatic psychotherapist and psychedelic educator and consultant. Co-author of peer-reviewed research on psychedelic medicines published in Current Opinion in Psychiatry and Frontiers in Neuroscience. Contributor to Australia's pioneering psilocybin trial for end-of-life depression and anxiety at St Vincent's Hospital Melbourne. M.A. Transpersonal Psychology (Sofia University).
Originally from Colombia and now an active member of Australia's psychedelic community, Diego brings both international perspective and practical experience to his work. He has contributed to Australia's pioneering psilocybin trial for end-of-life depression and anxiety at St. Vincent's Melbourne and has served in key roles within the non-profit sector and the Psychae Institute. His approach integrates Somatic and Transpersonal methods, reflecting his commitment to whole-person wellbeing.
Note: Diego's academic publications appear under the name Diego Pinzon Rubiano.